Greatbatch, Inc. Reports 2009 Third Quarter Results

CLARENCE, N.Y.–(BUSINESS WIRE)–Greatbatch, Inc. (NYSE:GB – News), today announced results for its third quarter ended October 2, 2009:

* CRM/Neuromodulation revenue growth of 5%
* Orthopaedic and Electrochem revenue negatively impacted by market slowdown
* GAAP operating results include impact of $34.5 million Electrochem litigation charge
* Cash flows from operations of $29 million
* Consolidation initiatives remain on track
* Annual operating margin guidance maintained on reduced full year revenue expectations


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button